Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older~* Patients with histologically proven (N)SCLC (all histological subtypes), treated with concurrent chemo- and radiotherapy.~* Ability to understand the protocol and willing to provide written informed consent~Exclusion Criteria:~* Concurrent participation in a clinical trial in which the subject is taking or receiving any investigational agent that may affect the frequency, severity or duration of mucositis.~* Pre-existent esophagitis.~* Receiving investigational treatment for the prevention or treatment of mucositis.~* Prior irradiation to the lung or head and neck region.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Caphosol (Type: ACTIVE_COMPARATOR): None
- No intervention (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).